Bullfrog AI Holdings, Inc. (BFRG)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Vininder Singh | Founder, Chairman & CEO | 707.67k | -- | 1970 |
Mr. Dane R. Saglio | Chief Financial Officer | 360k | -- | 1958 |
Mr. J. T. Koffenberger | Chief Information Officer | -- | -- | -- |
Hon. Thomas W. Chittenden X, DPHIL, Ph.D. | Chief Scientific Officer | -- | -- | -- |
Dr. Cetin Savkli Ph.D. | Chief AI Advisor & Member of Advisory Board | -- | -- | -- |
Mr. William Hirschman | Chief Commercial Officer | -- | -- | -- |
Dr. David P. Recker FACP, FACR, M.D. | Chief Medical Officer | -- | -- | 1958 |
Bullfrog AI Holdings, Inc.
- Sector:
- Healthcare
- Industry: Health Information Services
Description
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.
Corporate Governance
Recent Events
- Apr 09, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Mar 29, 202410-K: Periodic Financial ReportsSee Full Filing
- Mar 08, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Feb 26, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Feb 09, 20248-K: Corporate Changes & Voting MattersSee Full Filing
Upcoming Events
Upcoming Events Information Not Available